2 records matched your query
03878cam a22004934a 4500 001 32C680B02B0C11DE82774608A8D7520A 005 20220831010537 007 co cga 008 031112s2004 njua b 001 0 eng 010 $a 2003024925 020 $a 9781592597390 (e-book) 020 $a 1592597394 (e-book) 020 $a 9781588292285 (alk. paper) 020 $a 1588292282 (alk. paper) 035 $a (OCoLC)53443077 040 $a DNLM/DLC $c DLC $d SILO $d NLM $d OCLCQ $d BAKER $d IWO $d SILO 050 00 $a RC271.C5 $b A6722 2004 060 00 $a 2004 D-110 060 10 $a QV 269 $b A62953 2004 082 00 $a 616.99/4061 $2 22 245 0 $a Anticancer drug development guide : $b preclinical screening, clinical trials, and approval / $c edited by Beverly A. Teicher, Paul A. Andrews. 250 $a 2nd ed. 260 $a Totowa, N.J. : $b Humana Press, $c c2004. 300 $a xiv, 450 p. : $b ill. ; $c 26 cm. 440 0 $a Cancer drug discovery and development. 504 $a Includes bibliographical references and index. 505 0 $a High-volume screening / Michel PagaÌ -- High-throughput screening in industry / Michael D. Boisclair ... [et al.] -- The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd -- Human tumor screening / Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff -- Murine L1210 and P388 leukemias / William R. Waud -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery / Thomas Corbett ... [et al.] -- Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.] -- Specialized in vitro/in vivo procedures employed by the NCI in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.]. 505 0 $a Patient-like orthotopic metastatic models of human cancer / Robert M. Hoffman -- Preclinical models for combination therapy / Beverly A. Teicher -- Models for biomarkers and minimal residual tumor / Beverly A. Teicher -- Spontaneously occurring tumors in companion animals as models for drug development / David M. Vail and Douglas H. Thamm -- Nonclinical testing: from theory to practice / Denis Roy and Paul A. Andrews -- Nonclinical testing for oncology drug products / Paul A. Andrews and Denis Roy -- Nonclinical testing for oncology biologic products / Carolyn M. LaureniÌot, Denis Roy, and Paul A. Andrews -- 505 0 $a Working with the national cancer institute / Paul Thambi and Edward A. Sausville -- Phase I trial design and methodology for anticancer drugs / Patrick V. Acevedo, Deborah L. Toppmeyer, and Eric H. Rubin -- Phase II trials: conventional design and novel strategies in the era of targeted therapies / Keith T. Flaherty and Peter J. O'Dwyer -- 505 0 $a Drug development in Europe: the academic perspective / Chris Twelves ... [et al.] -- The phase III clinical cancer trial / Ramzi N. Dagher and Richard Pazdur -- Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective / Judy H. Chiao, Grant Williams, and Donna Griebel -- The role of the oncology drug advisory committee in the FDA review process for oncologic products / Leslie A. Vaccari -- FDA role in cancer drug development and requirements for approval / Susan Flamm Honig. 538 $a Minimum system requirements: Adobe reader 6.0 or later. 650 0 $a Antineoplastic agents $x Development. 650 12 $a Antineoplastic Agents $x standards. 650 22 $a Clinical Trials 650 22 $a Drug Approval 650 22 $a Drug Design. 650 22 $a Drug Evaluation, Preclinical. 700 1 $a Teicher, Beverly A., $d 1952- 700 1 $a Andrews, Paul A. 939 $a 5619269 941 $a 1 952 $l OVUX522 $d 20231021025456.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=32C680B02B0C11DE82774608A8D7520A 994 $a 02 $b IWOInitiate Another SILO Locator Search